Home LiteratureArticle Details
PMID: 7462697 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S.

Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers.

The Journal of infectious diseases ·Vol. 142 ·No. 6 ·1980-12-00 ·Pages 857-60

Mortiz AJ, Kunz C, Hofman H, Liehl E, Reeve P, Maassab HF

Abstract

A cold-recombinant influenza A virus, CR 22, derived from A/Ann Arbor/6/60 (H2N2) cold-adapted virus and A/Victoria/3/75 (H3N2) wild-type virus, was tested in adult volunteers. CR 22 induced only low-grade clinical reactions in volunteers who had low titers of serum antibodies. Virus could be reisolated from about one-third of the volunteers, but only at low titers. No revertant viruses were found, and there was no evidence for transmission of virus to unvaccinated volunteers housed in the close contact with the vaccinees. A high proportion of the volunteers seroconverted, and the mean titers of serum antibody after immunization suggest that a high degree of protection is induced by vaccination with liver CR 22 virus.

MeSH Terms
Animals Antibody Formation Chick Embryo Cold Temperature Double-Blind Method Humans Influenza A Virus, H3N2 Subtype Influenza A virus/genetics,immunology Influenza Vaccines/immunology Influenza, Human/immunology Recombination, Genetic
Chemicals
Influenza Vaccines
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Mortiz A J
Kunz C
Hofman H
Liehl E
Reeve P
Maassab H F
Article Info
Journal
The Journal of infectious diseases
Abbr.
J Infect Dis
ISSN
0022-1899
Published
1980-12-00
Pages
857-60
Language
English
Region
United States
NLM ID
0413675
Subset
IM
Grants
NIAID NIH HHS · 1.AI. 72521 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com